Pfizer Inc (NYSE:PFE)
$ 28.01 -0.17 (-0.6%) Market Cap: 158.72 Bil Enterprise Value: 215.50 Bil PE Ratio: 0 PB Ratio: 1.72 GF Score: 76/100

Pfizer Inc at SVB Leerink Global Healthcare (Virtual) Transcript

Feb 16, 2022 / 06:00PM GMT
Release Date Price: $49.68 (-0.22%)
David Reed Risinger
SVB Leerink Holdings LLC - Senior MD

Great. Good afternoon, everyone, and thank you so much for joining us for a discussion with Pfizer's hospital leadership team. It's very much my pleasure to welcome Angela Lukin, who is the Global President of Pfizer Hospital; Annaliesa Anderson, who is the Chief Scientific Officer of the Hospital Group and is also in charge of Bacterial Vaccines; and Jim Rusnak, who is Chief Development Officer for Hospital and also for Internal Medicine. We also have with us Chris Stevo, who is the Chief IR Officer for Pfizer.

And once again, I wanted to thank the participants and for the Pfizer leadership team members for joining us today.

Questions & Answers

David Reed Risinger
SVB Leerink Holdings LLC - Senior MD

I thought it would be great to kick off at a high level, Angela, by asking about the pivot from defense to offense. I mean, clearly, your business has largely resolved its manufacturing issues. And it would be great for you to set the stage for the vision for the Hospital segment.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot